| NCT ID | NCT05767151 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xiangya Hospital of Central South University |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2031-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2021-01-01 with a primary completion date of 2031-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.
Eligibility Criteria
Inclusion Criteria: 1. Participants were diagnosed by MDS Clinical Diagnostic Criteria for PD 2. Disease duration ≤ 2 years at baseline 3. Hoehn-Yahr stage ≤2 at baseline 4. The age of PD patients ranges from 30 to 75 years old 5. Participants were naive to antiparkinsonian therapy 6. Able to Written informed consent Exclusion Criteria: 1. Participants were diagnosed with parkinsonism-syndrome 2. Participants were treated with antiparkinsonian drugs at baseline 3. Participants with cognitive impairment 4. Unable to Written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05767151 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 75 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05767151 currently recruiting?
Yes, NCT05767151 is actively recruiting participants. Contact the research team at guojifeng2003@163.com for enrollment information.
Where is the NCT05767151 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT05767151 clinical trial?
NCT05767151 is sponsored by Xiangya Hospital of Central South University. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.